Related Experiment Video

Updated: Sep 29, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

400

SEOM-GECOD clinical guideline for unknown primary cancer (2021)

Ferrán Losa1, Isaura Fernández2, Olatz Etxaniz3

  • 1Hospital de Sant Joan Despí Moisés Broggi-ICO Hospitalet, Barcelona, Spain. ferran.losa@sanitatintegral.org.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|March 23, 2022
PubMed

Insights

Cancer of unknown primary site (CUP) presents as a diverse group of metastatic tumors where the origin is unidentified. Molecular characteristics and actionable mutations are crucial for managing this unique cancer entity.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Medicine

Background:

  • Cancer of unknown primary site (CUP) is a heterogeneous group of metastatic tumors.
  • Standard diagnostic methods often fail to identify the primary tumor origin in CUP cases.
  • CUP is recognized as a distinct entity with unique biological characteristics.

Purpose of the Study:

  • To summarize current diagnostic approaches for CUP.
  • To outline therapeutic strategies for CUP management.
  • To explore emerging molecular medicine developments for CUP.

Main Methods:

  • Review of diagnostic work-up procedures for CUP.
  • Analysis of current treatment guidelines for CUP.
  • Examination of recent advancements in molecular profiling and targeted therapies.

Main Results:

  • Molecular characteristics and actionable mutations are increasingly important in a significant subset of CUP patients.
  • Personalized treatment strategies based on molecular findings show promise.
  • New developments in molecular medicine offer potential for improved CUP management.

Conclusions:

  • Accurate diagnosis and understanding of CUP's specific biology are essential.
  • Molecular profiling can identify actionable targets, guiding personalized therapy.
  • Continued research in molecular medicine is vital for advancing CUP patient care.
Keywords:
CancerDiagnosisTreatmentUnknown primary site

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

218
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

875

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K